HEART NEWS and EVENTS
12/1/08 White Paper: Women's Heart Health at Stanford: Helping Women Live Longer, Healthier Lives [pdf, 7.8MB]
Cardiovascular Sex Differences Monthly Journal Club
6/10/08 medcast Implications of Embryonic Stem Cell Research on Women's Health "Using embryonic stem cells to better understand the first days of development may also lead to a better understanding of infertility and common birth defects..."
6/3/08 Asthma linked to heart disease and stroke in women
5/2/08 Some women more likely to miss or ignore heart attack warning signs
2/13/08 Straight from the Heart: Women's Heart Health Clinic treats gender specific diseases
CPR Guidelines for adults and children
Stanford women's cardiovascular health program was initiated in 2006, spearheaded by Stanford Cardiovascular Institute director Robert C. Robbins, M.D.
Our Mission
The Mission of “Women’s Heart Health at Stanford” is to:
- Enhance cardiovascular clinical care for women
- Provide women’s cardiovascular education in the surrounding communities and the Stanford academic community
- Advocate for and establish new research on sex differences in heart and vessel disease at Stanford and nationally
Leadership
Co-Director: Hannah Valantine, MD, Professor of Cardiovascular Medicine
Dr. Valantine, a cardiologist, is Senior Associate Dean for Diversity and Leadership at Stanford University Medical Center. She is President of the Western States Affiliate Board of the American Heart Association and a frequent speaker at national and international meetings on heart disease and women’s issues.
Co-Director: Marcia Stefanick, PhD, Professor of Medicine-Prevention Research, and, by courtesy, of Obstetrics and Gynecology
Dr. Stefanick is active in a national Think Tank of cardiologists and researchers focused on Women and Heart Disease, is promoting the Investigation of Sex and Gender Differences in Cardiovascular Research across the wide spectrum of research areas represented by Stanford CVI members, and is an acknowledged expert on women’s health issues (especially cardiovascular) and disease prevention, is frequently interviewed and sought-after as a speaker nationally and internationally.
Clinical Director: Jennifer Tremmel, MD, SM (Epidemiology). Dr. Tremmel is an Instructor and Interventional Cardiologist in the Division of Cardiovascular Medicine. She also trained in Preventive Cardiology and was a Postdoctoral Research Scholar at the Stanford Prevention Research Center. Dr. Tremmel is the Clinical Director of Women’s Heart Health at Stanford, as well as the Director of the Stanford Secondary Prevention Program. Dr. Tremmel’s research interests include sex differences in coronary artery disease, the determinants of vascular access complications, and the effects of weight on coronary physiology and cardiac outcomes. She has also evaluated the use of drug-eluting stents in transplant arteriopathy and keeps Stanford’s Tako-Tsubo Patient Registry. She is currently investigating sex differences in the occurrence of coronary endothelial dysfunction, diffuse plaque deposition, and microvascular disease in women and men presenting with chest pain, but having “normal” coronary arteries by angiography.
